Mairs & Power Inc Abbott Laboratories Transaction History

Mairs & Power Inc

$10.2 Billion
Q1 2024

A detailed history of Mairs & Power Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mairs & Power Inc holds 1,249,673 shares of ABT stock, worth $130 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

1,249,673

Previous 1,285,461 2.78%

Holding current value

$130 Million

Previous $141 Million 0.39%

% of portfolio

1.39%

Previous 1.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $3.92 Million - $4.33 Million	-35,788 Reduced 2.78%	1,249,673 $142 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.22 Million - $1.49 Million	-13,538 Reduced 1.04%	1,285,461 $141 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $443,259 - $531,836	-4,640 Reduced 0.36%	1,298,999 $126 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $1.55 Million - $1.72 Million	-15,333 Reduced 1.16%	1,303,639 $142 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $1.25 Million - $1.48 Million	-12,948 Reduced 0.97%	1,318,972 $134 Million

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $10.1 Million - $11.9 Million	-106,272 Reduced 7.39%	1,331,920 $146 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $907,608 - $1.05 Million	-9,380 Reduced 0.65%	1,438,192 $139 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $1.6 Million - $1.93 Million	-15,657 Reduced 1.07%	1,447,572 $157 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $4.15 Million - $5.06 Million	-36,370 Reduced 2.43%	1,463,229 $173 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1.05 Million - $1.29 Million	-9,087 Reduced 0.6%	1,499,599 $211 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $198,555 - $219,660	1,702 Added 0.11%	1,508,686 $178 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $5.88 Million - $6.92 Million	55,536 Added 3.83%	1,506,984 $175 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $1.03 Million - $1.22 Million	-9,497 Reduced 0.65%	1,451,448 $174 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $2.31 Million - $2.51 Million	-21,959 Reduced 1.48%	1,460,945 $160 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $9.89 Million - $12 Million	-107,916 Reduced 6.78%	1,482,904 $161 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $12.1 Million - $15.5 Million	-158,646 Reduced 9.07%	1,590,820 $145 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $12.7 Million - $18.6 Million	-202,919 Reduced 10.39%	1,749,466 $138 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $30.1 Million - $33.5 Million	-382,866 Reduced 16.4%	1,952,385 $170 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $12.7 Million - $13.7 Million	-154,768 Reduced 6.22%	2,335,251 $195 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $37.9 Million - $44.3 Million	-520,626 Reduced 17.29%	2,490,019 $209 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $10.4 Million - $12.6 Million	-156,850 Reduced 4.95%	3,010,645 $241 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $17.6 Million - $20 Million	-269,098 Reduced 7.83%	3,167,495 $229 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $24.9 Million - $30 Million	-408,755 Reduced 10.63%	3,436,593 $252 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $23.7 Million - $26.2 Million	-412,021 Reduced 9.68%	3,845,348 $235 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $16.1 Million - $18.2 Million	-286,016 Reduced 6.3%	4,257,369 $255 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $1.44 Million - $1.54 Million	-26,869 Reduced 0.59%	4,543,385 $259 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $220 Million - $245 Million	4,570,254	4,570,254 $244 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account